Clinical Trial Update: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

View source ↗

Summary

Completed serology study in children aged 12 to 23 months who received the Measles, Mumps, and Rubella (MMR) vaccine. Sponsored by Bio-Manguinhos/Fiocruz.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella

Drugs mentioned

• Measles, Mumps, and Rubella vaccine (Measles, Mumps, and Rubella vaccine)

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Mumps, Rubella | Status: COMPLETED